Cubist Systematic Strategies, LLC Novo Cure LTD Transaction History
Cubist Systematic Strategies, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 335,218 shares of NVCR stock, worth $6.45 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
335,218
Previous 103,752
223.1%
Holding current value
$6.45 Million
Previous $1.62 Million
516.22%
% of portfolio
0.07%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$233 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$227 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$171 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$92.6 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$52.7 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.02B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...